missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. EMMPRIN/CD147 Antibody (BSG/9223R), Novus Biologicals™
  7. 18643894

EMMPRIN/CD147 Antibody (BSG/9223R), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-23674-20ug

 View more versions of this product

Product Code. 18643894

  • 268.00 € / 20µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

EMMPRIN/CD147 Monoclonal antibody specifically detects EMMPRIN/CD147 in Human samples. It is validated for ELISA, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

EMMPRIN/CD147
Monoclonal
0.2 mg/mL
ELISA, Immunohistochemistry-Paraffin : 1-2 μg/mL
5F7, basigin, basigin (Ok blood group), CD147, CD147 antigen, Collagenase stimulatory factor, EMMPRINTCSF, Extracellular matrix metalloproteinase inducer, Leukocyte activation antigen M6, M6, OK, OK blood group antigen, Tumor cell-derived collagenase stimulatory factor
Recombinant full-length human EMMPRIN/CD147 protein
20 μg
Cancer, Signal Transduction, Vision
682
Store at 4°C.
IgG κ
ELISA, Immunohistochemistry (Paraffin)
BSG/9223R
Unconjugated
10 mM PBS with 0.05% BSA
Rabbit
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.